BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
http://www.bayer.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees116,428

Key Executives

NameTitlePayExercisedYear Born
Mr. Werner BaumannChairman of Management & CEO4.32MN/A1962
Mr. Wolfgang U. NicklCFO & Member of Management Board1.53MN/A1969
Mr. Liam CondonPres of Bayer Crop Science Division & Member of Management Board2.22MN/A1968
Dr. Kemal MalikHead of Innovation & Member of Management Board2.07MN/A1962
Dr. Hartmut KlusikHead of HR, Technology & Sustainability, Labor Director and Member of Management Board2.01MN/A1956
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Corporate Governance

Bayer Aktiengesellschaft’s ISS Governance QualityScore as of June 25, 2019 is 6. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.